Adaptive Biotechnologies Corporation Profile Avatar - Palmy Investing

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer …

Biotechnology
US, Seattle [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ADPT's Analysis
CIK: 1478320 CUSIP: 00650F109 ISIN: US00650F1093 LEI: - UEI: -
Secondary Listings
ADPT has no secondary listings inside our databases.